Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-announces-exclusive-license-and-option-agreement-for-potential-first-in-class-clinical-stage-45192260/?utm_source=whatsapp&utm_medium=social&utm_campaign=share